According to the IMARC Group, Molecular cytogenetics includes the biomedical research of DNA mechanisms to investigate genetic mutations and disorders.
It analyzes the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, particularly in medicinal and cancer-related genetics.
Several techniques, such as DNA isolation, DNA amplification, gene screens, virtual karyotyping and fluorescence in-situ hybridization (FISH), are commonly used for molecular cytogenetics.
These techniques are highly beneficial in diagnosing and treating various malignant tumors and hematological malignancies.Request for a free sample copy of this report: https://www.imarcgroup.com/molecular-cytogenetics-market/requestsampleThe growing prevalence of cancer and other genetic disorders is primarily driving the market growth.
Furthermore, the widespread adoption of targeted therapies, such as FISH and Comparative Genomic Hybridization (CGH), that help in analyzing cancer progression stages and provide personalized treatment to the patient is further propelling the market.
Additionally, several technological advancements have led to the development of improved consumables, reagents, kits, etc., that aid in generating accurate and reliable clinical-pathological test results, thereby driving the global market.Explore Report Description: https://www.imarcgroup.com/molecular-cytogenetics-marketKey Market Segmentation:IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025.